Researchers challenge long-standing theory guiding nanoparticle treatment of tumors

  • 📰 physorg_com
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 55%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Researchers at the University of Toronto have developed a new theory to explain how nanoparticles enter and exit the tumors they are meant to treat, potentially rewriting an understanding of cancer nanomedicine that has guided research for nearly four decades.

walls and transport vesicles that carry them across these walls. The researchers showed that nanoparticles will re-enter the bloodstream following lymphatic drainage, and hypothesized that these nanoparticles will eventually return to the tumor for another opportunity to treat it.

Nguyen noted that the field of nanomedicine has evolved since the publication of the nanoparticle entry study in 2020."We got more pushback from other researchers on that study compared to this one," he said."People have started to accept that the EPR effect is flawed.", future research could address this issue through nanoparticle treatments that prevent lymphatic drainage.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 388. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers connect Alzheimer's-associated genetic variants with brain cell functionResearch reveals new non-coding genetic variants associated with Alzheimer's disease functioning in microglia -- brain cells already implicated in the progression of this often-fatal neurodegenerative condition.
Source: ScienceDaily - 🏆 452. / 53 Read more »

Researchers pioneer safe nanocarrier system for treating bacterial infectionsAntibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at Linköping University, Sweden.
Source: physorg_com - 🏆 388. / 55 Read more »